These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9136070)

  • 1. A summary statistic for measuring change from baseline.
    Donahue RM
    J Biopharm Stat; 1997 May; 7(2):287-99. PubMed ID: 9136070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of covariance (ANCOVA) with difference scores.
    Jamieson J
    Int J Psychophysiol; 2004 May; 52(3):277-83. PubMed ID: 15094250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy to evaluate a covariate by group interaction in an analysis of covariance.
    Leon AC; Portera L; Lowell K; Rheinheimer D
    Psychopharmacol Bull; 1998; 34(4):805-9. PubMed ID: 10513456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new nonparametric approach for baseline covariate adjustment for two-group comparative studies.
    Schacht A; Bogaerts K; Bluhmki E; Lesaffre E
    Biometrics; 2008 Dec; 64(4):1110-6. PubMed ID: 18266888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
    Liu GF; Lu K; Mogg R; Mallick M; Mehrotra DV
    Stat Med; 2009 Sep; 28(20):2509-30. PubMed ID: 19610129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.
    Egbewale BE; Lewis M; Sim J
    BMC Med Res Methodol; 2014 Apr; 14():49. PubMed ID: 24712304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilcoxon-Mann-Whitney test: stratify or not?
    Qu Y; Zhao YD; Rahardja D
    J Biopharm Stat; 2008; 18(6):1103-11. PubMed ID: 18991110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting sample size for anticipated dropouts in clinical trials.
    Overall JE; Shobaki G; Shivakumar C; Steele J
    Psychopharmacol Bull; 1998; 34(1):25-33. PubMed ID: 9564195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many repeated measurements are useful?
    Overall JE
    J Clin Psychol; 1996 May; 52(3):243-52. PubMed ID: 8835686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of chance baseline differences in repeated measurement designs.
    Overall JE; Doyle SR
    J Biopharm Stat; 1994 Jul; 4(2):199-216. PubMed ID: 7951275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.